Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Belgravia Hartford Capital Inc C.BLGV

Alternate Symbol(s):  BLGVF

Belgravia Hartford Capital Inc. is a Canada-based investment holding company focused on growing its assets and holdings and increasing its net asset value (NAV). It invests in a portfolio of private and public companies. It takes a multi-sector investment approach, with emphasis on the resources and commodities sectors. The Company's investments are considered high-risk holdings, and it may... see more

Recent & Breaking News (CSE:BLGV)

Building Upon Successful Foundations

Jonathon Brown August 24, 2018

BELGRAVIA provides update on its Dermatology Subsidiary

GlobeNewswire August 24, 2018

BELGRAVIA CAPITAL Update on Proxy Solicitation of Tartisan Nickel

GlobeNewswire August 24, 2018

BELGRAVIA Intends to Replace the Board of Tartisan Nickel for Failure to Perform

GlobeNewswire August 7, 2018

BELGRAVIA corporate update

GlobeNewswire July 18, 2018

Belgravia Dermatology Completes Identification of Initial Drug Targets Within the Skin Endocannabinoid System and Also Identifies Bio Markers for Pre Clinical Work in Acne

GlobeNewswire June 18, 2018

Belgravia Capital Inc., Expansion & Growth for Belgravia, CEO Clip Video

Newsfile June 11, 2018

BELGRAVIA CAPITAL completes acquisition of interest in R&D Pharma Corp., a Canadian corporation building a vertically integrated medical cannabis business in Jamaica

GlobeNewswire May 30, 2018

Belgravia Completes Transition of ICP Organics to Dermatology Product Development, Renames ICP Organics to Belgravia Dermatology Inc., and Appoints Sidney Himmel Director of Belgravia Dermatology

GlobeNewswire May 11, 2018

Belgravia Appoints Dr. Sam Hanna Chief Medical Officer of Cannabis Dermatology Division

GlobeNewswire April 18, 2018

BELGRAVIA CAPITAL adds to expertise in corporate development and expands medical advisory committee

GlobeNewswire March 12, 2018

BELGRAVIA CAPITAL signs Binding Letter of Intent with R&D Pharma Corp., a developer of a vertically integrated medicinal cannabis business in Jamaica, to invest Canadian $1,000,000

GlobeNewswire February 28, 2018

BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry

GlobeNewswire January 25, 2018

BELGRAVIA CAPITAL INTERNATIONAL announces closing of private placement

GlobeNewswire January 12, 2018

BELGRAVIA CAPITAL INTERNATIONAL receives cash payment, appoints renowned Dermatologist as special advisor to ICP Organics, and provides updates on additional blockchain developments

GlobeNewswire January 10, 2018

BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.

GlobeNewswire January 4, 2018

BELGRAVIA CAPITAL INTERNATIONAL moves to build fully-owned subsidiary in Blockchain and Cannabis Industry

GlobeNewswire January 3, 2018

BELGRAVIA CAPITAL Corporate Update

GlobeNewswire December 5, 2017

CSE New Listing - Belgravia Capital International Commences Trading on the Canadian Securities Exchange - Video News Alert on InvestmentPitch.com

Newsfile November 29, 2017

IC Potash announces trading date on Canadian Securities Exchange under new name ‘Belgravia Capital International’

GlobeNewswire November 22, 2017